Last update:

Medications news

Medications

Two powerful drugs now adding to US overdose crisis

Emerging reports show that two little-known drugs are making lethal new contributions to America's drug overdose crisis.

Medications

Newer rheumatoid arthritis drug might raise heart, cancer risks

(HealthDay)—Finding the right medication for rheumatoid arthritis isn't easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms.

Medications

Scientists find link between antibiotics and colon cancer

Scientists from the University of Aberdeen, NHS Grampian and Queen's University Belfast have found that antibiotic use may increase the risk of developing colon cancer, potentially more so among younger people.

Medications

New data on drug metabolism and distribution in the eye

Severe visual illnesses are increasing in our society, and effective treatments are missing for diseases as age-related macular degeneration, diabetic retinopathy, and glaucoma. Both industry and academia are highly interested ...

Medications

Active ingredient in cannabis protects aging brain cells

Decades of research on medical cannabis has focused on the compounds THC and CBD in clinical applications. But less is known about the therapeutic properties of cannabinol (CBN). Now, a new study by Salk scientists shows ...

Medications

Psoriasis treatments can be life-changing

If you suffer from psoriasis, vibrant, clear skin is no longer out of reach. According to Rush dermatologists, new innovative treatments can help you put your best face forward.

Medications

Skyrizi approved for psoriatic arthritis

(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.

Medications

FDA limits use of two COVID antibody treatments

The U.S. Food and Drug Administration said Monday that it will curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant.

Medications

Semaglutide superior to liraglutide for weight loss

(HealthDay)—Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous ...

Medications

More than 2 dozen drugmakers to make Merck's COVID-19 pill

A U.N.-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck's COVID-19 pill to supply 105 developing countries.

Medications

Emergency department interventions cut opioid perscription rates

(HealthDay)—Most emergency department interventions aimed at cutting opioid prescribing cut the prescription rate but not the prescribed opioid quantity, according to a review published online Jan. 13 in JAMA Network Open.

Medications

Antifreeze cream prevents frostbite injuries to skin

Skiers, hikers, soldiers and others exposed to extreme cold temperatures can experience frostbite—a painful injury that occurs when ice crystals form in the skin. Many extremely cold areas are also remote, and delays in ...

Medications

New tool assesses evolutionary risks of antibiotics

Bacteria have dangerously evolved to thwart many of the medicines that were designed to kill them. As a result, a growing antibiotic resistance crisis is responsible for more than 700,000 deaths each year, emerging as one ...

Medications

Behavioural outcomes of antidepressant treatment

Mood and anxiety disorders are some of the biggest contributors to morbidity worldwide, and may be lethal. Appropriate treatment is therefore paramount and antidepressants is the first choice of pharmacological treatment ...